Skip to main content
Andrew Cowan, MD, Oncology, Seattle, WA, UW Medicine/Harborview Medical Center

AndrewJohnCowanMD

Oncology Seattle, WA

Hematologic Oncology

Associate Professor, Medical Oncology at University of Washington; Associate Professor, Fred Hutchinson Cancer Research Center

Dr. Cowan is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Connect with other colleagues in the same hospital or clinic
  • Search all U.S. specialist profiles and refer a patient
  • Read the latest clinical news and earn CME/CEU credits

See Dr. Cowan's full profile

Already have an account?

Summary

  • As an associate professor of medicine in the Div. of Medical Oncology at the University of Washington School of Medicine, my focus is in plasma cell disorders, specifically, MM and AL amyloidosis. I am involved in a variety of clinical research projects, both retrospective and prospective studies. I have a special interest in multiple myeloma and AL amyloidosis.

    My clinical and research focus is on immunotherapy for MM, including CAR T cells; health services research in MM, and health informatics.
  • Upcoming OncLive Summit

Education & Training

  • University of Washington
    University of WashingtonFellowship, Hematology and Medical Oncology, 2012 - 2015
  • Boston University Medical Center
    Boston University Medical CenterResidency, Internal Medicine, 2009 - 2011
  • Boston University Medical Center
    Boston University Medical CenterInternship, Internal Medicine, 2008 - 2009
  • University of Washington School of Medicine
    University of Washington School of MedicineClass of 2008

Certifications & Licensure

  • AK State Medical License
    AK State Medical License 2022 - 2023
  • WA State Medical License
    WA State Medical License 2017 - 2023
  • MA State Medical License
    MA State Medical License 2011 - 2013
  • American Board of Internal Medicine Internal Medicine
  • American Board of Internal Medicine Hematology
  • American Board of Internal Medicine Medical Oncology

Clinical Trials

Publications & Presentations

PubMed

Abstracts/Posters

  • Response to Bcma CAR-T Cells Correlates with Pretreatment Target Antigen Density and Is Improved By Small Molecule Inhibition of Gamma Secretase
    Andrew J. Cowan, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
  • Depth of Response to Daratumumab (DARA), Lenalidomide, Bortezomib, and Dexamethasone (RVd) Improves over Time in Patients (pts) with Transplant-Eligible Newly Diagnose...
    Andrew J. Cowan, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
  • Efficacy and Safety of Fully Human Bcma CAR T Cells in Combination with a Gamma Secretase Inhibitor to Increase Bcma Surface Expression in Patients with Relapsed or Re...
    Andrew J. Cowan, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
  • Join now to see all

Lectures

  • Pembrolizumab in Combination with Standard RCHOP Therapy for Previously Untreated Diffuse Large B-Cell Lymphoma 
    2018 ASH Annual Meeting - San Diego, CA - 12/1/2018
  • Prolonged Lenalidomide Therapy in Multiple Myeloma Patients Does Not Impact Autologous PBSC Mobilization: A Single Center Retrospective Analysis 
    2018 ASH Annual Meeting - San Diego, CA - 12/1/2018

Press Mentions

  • Fred Hutch at ASH: Latest CAR T Data – BCMA, CD19, CD20 – plus New Insights on Transplantation, Gene Therapy – and More
    Fred Hutch at ASH: Latest CAR T Data – BCMA, CD19, CD20 – plus New Insights on Transplantation, Gene Therapy – and MoreNovember 21st, 2019
  • Clinical Challenges: Quadruplet Therapy in Multiple Myeloma
    Clinical Challenges: Quadruplet Therapy in Multiple MyelomaJune 2nd, 2021

Grant Support

  • T32 Oncology Training GrantNIH2014–2015

Committees

  • Reviewer, Scientific Review Committee, FHCRC 2016 - Present

Professional Memberships

Hospital Affiliations